Stock of interest

January 05, 2008

Osiris Therapeutics Inc.

Shares rose $1.29 to $13.86 after the Columbia-based company said the U.S. government will pay it up to $224.7 million to develop and stockpile its stem cell treatment for radiation exposure.

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.